- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 25, 2025 | 120.16M sh |
| Long Term Debt | Q2 2025 · Mar 28, 2025 | $2.63B |
| Long Term Debt | Q2 2025 · Sep 27, 2024 | $1.35B |
| Cash And Equivalents | Q2 2025 · Mar 28, 2025 | $1.2B |
| Cash And Equivalents | Q2 2025 · Sep 27, 2024 | $1.14B |
| Stockholders Equity | Q2 2025 · Mar 28, 2025 | $3.86B |
| Stockholders Equity | Q2 2025 · Sep 27, 2024 | $4.55B |
| Current Liabilities | Q2 2025 · Mar 28, 2025 | $2.96B |
| Current Liabilities | Q2 2025 · Sep 27, 2024 | $4.08B |
| Current Assets | Q2 2025 · Mar 28, 2025 | $4.44B |
| Current Assets | Q2 2025 · Sep 27, 2024 | $4.9B |
| Total Assets | Q2 2025 · Mar 28, 2025 | $11.21B |
| Total Assets | Q2 2025 · Sep 27, 2024 | $11.76B |
| Shares Diluted | Q2 2025 · Mar 29, 2024 | 126.21M sh |
| Shares Diluted | Q2 2025 · Mar 29, 2024 | 126.51M sh |
| Stock Repurchased | Q2 2025 · Mar 29, 2024 | $195.46M |
| Dividends Paid | Q2 2025 · Mar 29, 2024 | $70.14M |
| Capex | Q2 2025 · Mar 29, 2024 | $45.11M |
| Operating Cash Flow | Q2 2025 · Mar 29, 2024 | $375.54M |
| Eps Diluted | Q2 2025 · Mar 29, 2024 | $1.28 |
| Eps Diluted | Q2 2025 · Mar 29, 2024 | $2.65 |
| Eps Basic | Q2 2025 · Mar 29, 2024 | $1.29 |
| Eps Basic | Q2 2025 · Mar 29, 2024 | $2.66 |
| Sga Expense restated | Q2 2025 · Mar 29, 2024 | $528.72M |
| Sga Expense restated | Q2 2025 · Mar 29, 2024 | $1.05B |
| Net Income | Q2 2025 · Mar 29, 2024 | $162.11M |
| Net Income | Q2 2025 · Mar 29, 2024 | $333.72M |
| Operating Income restated | Q2 2025 · Mar 29, 2024 | $183.24M |
| Operating Income restated | Q2 2025 · Mar 29, 2024 | $325.24M |
| Gross Profit restated | Q2 2025 · Mar 29, 2024 | $711.96M |
| Gross Profit restated | Q2 2025 · Mar 29, 2024 | $1.38B |